U.S. Court in Maine Tosses AstraZeneca’s Challenge to Maine Law Protecting Use of Contract Pharmacies for 340B Drugs
- July 31, 2026
- Written by AHLA Legal Staff
The U.S. District Court for the District of Maine dismissed July 27 AstraZeneca Pharmaceutical LP’s challenge to a Maine statute that requires pharmaceutical manufacturers to deliver their drugs under the 340B program to an unlimited number of contract pharmacies.
ARTICLE TAGS
You must be logged in to access this content.